Back
NovaBay Pharmaceuticals Vs. Nebius Group NV Industry Stock Comparison
Sell
49
NBY
NovaBay Pharmaceuticals
Last Price:
$0.61
Seasonality Move:
15.02%
Sell
42
NBIS
Nebius Group NV
Last Price:
$31.07
Seasonality Move:
-3.02%
Sell
49
NovaBay Pharmaceuticals (NBY)
is a Sell
Is NovaBay Pharmaceuticals a Buy, Sell or Hold?
-
The current NovaBay Pharmaceuticals [NBY] share price is $0.62. The Score for NBY is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
-
NBY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
42
Nebius Group NV (NBIS)
is a Sell
Is Nebius Group NV a Buy, Sell or Hold?
-
The current Nebius Group NV [NBIS] share price is $31.18. The Score for NBIS is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
-
NBIS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NBY Stock Price Chart
What is NovaBay Pharmaceuticals's stock price today?
-
The NovaBay Pharmaceuticals share price today is $0.62The current trend is relatively stagnant and NBY is experiencing slight buying pressure.
NBIS Stock Price Chart
What is Nebius Group NV's stock price today?
-
The Nebius Group NV share price today is $31.18Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NBIS is experiencing buying pressure, which is a positive indicator for future bullish movement.
NBY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.01 | Sell |
| Relative Strength Index (14 RSI): | 56.07 | Buy |
| Chaikin Money Flow: | -8007 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.54 - 0.6) | Buy |
| Bollinger Bands (100): | (0.51 - 0.69) | Buy |
NBIS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.02 | Buy |
| Relative Strength Index (14 RSI): | 59.25 | Buy |
| Chaikin Money Flow: | 2925988 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (25.81 - 32.69) | Buy |
| Bollinger Bands (100): | (17.18 - 26.62) | Buy |
NBY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.58 | Buy |
| 20-day SMA: | 0.56 | Buy |
| 50-day SMA: | 0.63 | Sell |
| 200-day SMA: | 1.71 | Sell |
| 8-day EMA: | 0.59 | Buy |
| 20-day EMA: | 0.58 | Buy |
| 50-day EMA: | 0.63 | Sell |
| 200-day EMA: | 4.39 | Sell |
NBIS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 28.57 | Buy |
| 20-day SMA: | 30.03 | Buy |
| 50-day SMA: | 24.84 | Buy |
| 200-day SMA: | 20.42 | Buy |
| 8-day EMA: | 29.09 | Buy |
| 20-day EMA: | 28.44 | Buy |
| 50-day EMA: | 25.83 | Buy |
| 200-day EMA: | 21.52 | Buy |
NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.44 per share, and an increase next year of $0.44 per share.
Nebius Group NV Earnings Growth & NBIS Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
NovaBay Pharmaceuticals Technical Analysis
| Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 19 | 20 | 23 | 24 | 26 | 27 | 30 | 31 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Nebius Group NV Technical Analysis
| Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 19 | 20 | 23 | 24 | 26 | 27 | 30 | 31 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||